Literature DB >> 29237044

Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction.

Nicholas Child1,2, Gonca Suna2,3, Darius Dabir1,4, May-Lin Yap1, Toby Rogers1,3, Misha Kathirgamanathan1, Eduardo Arroyo-Ucar1,5, Rocio Hinojar1, Islam Mahmoud1, Christopher Young6, Olaf Wendler7, Manuel Mayr2, Banher Sandhu1, Geraint Morton8, Marion Muhly-Reinholz9, Stefanie Dimmeler9, Eike Nagel1,10, Valentina O Puntmann1,10,11.   

Abstract

Aims: To determine the bioequivalence of several T1 mapping sequences in myocardial characterization of diffuse myocardial fibrosis. Methods and results: We performed an intra-individual sequence comparison of three types of T1 mapping sequences [MOdified Look-Locker Inversion recovery (MOLLI), Shortened MOdified Look-Locker Inversion recovery ((sh)MOLLI), and SAturation recovery single-SHot Acquisition (SASHA)]. We employed two model diseases of diffuse interstitial fibrosis [patients with non-ischaemic dilated cardiomyopathy (NIDCM), n = 32] and aortic stenosis [(AS), n = 25)]. Twenty-six healthy individuals served as controls. Relationship with collagen volume fraction (CVF) was assessed using endomyocardial biopsies (EMB) intraoperatively in 12 AS patients. T2 mapping (GraSE) was also performed. Myocardial native T1 with MOLLI and shMOLLI showed, firstly, an excellent discriminatory accuracy between health and disease [area under the curves (P-value): 0.94 (0.88-0.99); 0.87 (0.79-0.94); 0.61 (0.49-0.72)], secondly, relationship between histological CVF [native T1 MOLLI vs. shMOLLI vs. SASHA: r = 0.582 (P = 0.027), r = 0.524 (P = 0.046), r = 0.443 (P = 0.150)], and thirdly, with native T2 [r = 0.628(P < 0.001), r = 0.459 (P = 0.003), r = 0.211 (P = 0.083)]. The respective relationships for extracellular volume fraction with CVF [r = 0.489 (P = 0.044), r = 0.417 (0.071), r = 0.353 (P = 0.287)] were significant for MOLLI, but not other sequences. In AS patients, native T2 was significantly higher compared to controls, and associated with levels of C-reactive protein and troponin.
Conclusion: T1 mapping sequences differ in their bioequivalence for discrimination between health and disease as well as associations with diffuse myocardial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29237044     DOI: 10.1093/ehjci/jex309

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  21 in total

1.  Detection of Myocardial Fibrosis and Left Ventricular Dysfunction with Cardiac MRI in a Hypertensive Swine Model.

Authors:  Baiyan Zhuang; Chen Cui; Arlene Sirajuddin; Jian He; Xin Wang; Guangxin Yue; Xuejing Duan; Hongyue Wang; Andrew E Arai; Shihua Zhao; Minjie Lu
Journal:  Radiol Cardiothorac Imaging       Date:  2020-08-27

2.  T1 and ADC histogram parameters may be an in vivo biomarker for predicting the grade, subtype, and proliferative activity of meningioma.

Authors:  Tiexin Cao; Rifeng Jiang; Lingmin Zheng; Rufei Zhang; Xiaodan Chen; Zongmeng Wang; Peirong Jiang; Yilin Chen; Tianjin Zhong; Hu Chen; PuYeh Wu; Yunjing Xue; Lin Lin
Journal:  Eur Radiol       Date:  2022-08-12       Impact factor: 7.034

3.  Radiomic Analysis of Myocardial Native T1 Imaging Discriminates Between Hypertensive Heart Disease and Hypertrophic Cardiomyopathy.

Authors:  Ulf Neisius; Hossam El-Rewaidy; Shiro Nakamori; Jennifer Rodriguez; Warren J Manning; Reza Nezafat
Journal:  JACC Cardiovasc Imaging       Date:  2019-01-16

4.  Tissue characterisation and myocardial mechanics using cardiac MRI in children with hypertrophic cardiomyopathy.

Authors:  Sudeep Sunthankar; David A Parra; Kristen George-Durrett; Kimberly Crum; Joshua D Chew; Jason Christensen; Frank J Raucci; Meng Xu; James C Slaughter; Jonathan H Soslow
Journal:  Cardiol Young       Date:  2019-11-26       Impact factor: 1.093

Review 5.  Basics of magnetic resonance imaging and quantitative parameters T1, T2, T2*, T1rho and diffusion-weighted imaging.

Authors:  Suraj D Serai
Journal:  Pediatr Radiol       Date:  2021-04-15

6.  Characterization of interstitial diffuse fibrosis patterns using texture analysis of myocardial native T1 mapping.

Authors:  Hossam El-Rewaidy; Ulf Neisius; Shiro Nakamori; Long Ngo; Jennifer Rodriguez; Warren J Manning; Reza Nezafat
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

7.  Aortic stiffness is independently associated with interstitial myocardial fibrosis by native T1 and accelerated in the presence of chronic kidney disease.

Authors:  Mengzhen Chen; Luca Arcari; Juergen Engel; Tilo Freiwald; Steffen Platschek; Hui Zhou; Hafisyatul Zainal; Stefan Buettner; Andreas M Zeiher; Helmut Geiger; Ingeborg Hauser; Eike Nagel; Valentina O Puntmann
Journal:  Int J Cardiol Heart Vasc       Date:  2019-06-26

8.  Comparison of short axis and long axis acquisitions of T1 and extracellular volume mapping using MOLLI and SASHA in patients with myocardial infarction and healthy volunteers.

Authors:  Christos G Xanthis; David Nordlund; Robert Jablonowski; Håkan Arheden
Journal:  BMC Med Imaging       Date:  2019-02-22       Impact factor: 1.930

9.  Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy.

Authors:  Paweł Rubiś; Ewa Dziewięcka; Magdalena Szymańska; Robert Banyś; Małgorzata Urbańczyk-Zawadzka; Maciej Krupiński; Małgorzata Mielnik; Sylwia Wiśniowska-Śmiałek; Aleksandra Karabinowska; Piotr Podolec; Mateusz Winiarczyk; Matylda Gliniak; Monika Kaciczak; Jan Robak; Arman Karapetyan; Ewa Wypasek
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

10.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.